1 | Representative(s) Bean offered the following: |
2 |
|
3 | Amendment (with title amendment) |
4 | Remove the entire body and insert: |
5 | Section 1. Paragraph (a) of subsection (3) of section |
6 | 400.23, Florida Statutes, is amended to read: |
7 | 400.23 Rules; evaluation and deficiencies; licensure |
8 | status.-- |
9 | (3)(a) The agency shall adopt rules providing for the |
10 | minimum staffing requirements for nursing homes. These |
11 | requirements shall include, for each nursing home facility, a |
12 | minimum certified nursing assistant staffing of 2.3 hours of |
13 | direct care per resident per day beginning January 1, 2002, |
14 | increasing to 2.6 hours of direct care per resident per day |
15 | beginning January 1, 2003, and increasing to 2.9 hours of direct |
16 | care per resident per day beginning July 1, 2006 2005. Beginning |
17 | January 1, 2002, no facility shall staff below one certified |
18 | nursing assistant per 20 residents, and a minimum licensed |
19 | nursing staffing of 1.0 hour of direct resident care per |
20 | resident per day but never below one licensed nurse per 40 |
21 | residents. Nursing assistants employed under s. 400.211(2) may |
22 | be included in computing the staffing ratio for certified |
23 | nursing assistants only if they provide nursing assistance |
24 | services to residents on a full-time basis. Each nursing home |
25 | must document compliance with staffing standards as required |
26 | under this paragraph and post daily the names of staff on duty |
27 | for the benefit of facility residents and the public. The agency |
28 | shall recognize the use of licensed nurses for compliance with |
29 | minimum staffing requirements for certified nursing assistants, |
30 | provided that the facility otherwise meets the minimum staffing |
31 | requirements for licensed nurses and that the licensed nurses so |
32 | recognized are performing the duties of a certified nursing |
33 | assistant. Unless otherwise approved by the agency, licensed |
34 | nurses counted toward the minimum staffing requirements for |
35 | certified nursing assistants must exclusively perform the duties |
36 | of a certified nursing assistant for the entire shift and shall |
37 | not also be counted toward the minimum staffing requirements for |
38 | licensed nurses. If the agency approved a facility's request to |
39 | use a licensed nurse to perform both licensed nursing and |
40 | certified nursing assistant duties, the facility must allocate |
41 | the amount of staff time specifically spent on certified nursing |
42 | assistant duties for the purpose of documenting compliance with |
43 | minimum staffing requirements for certified and licensed nursing |
44 | staff. In no event may the hours of a licensed nurse with dual |
45 | job responsibilities be counted twice. |
46 | Section 2. Subsections (2) and (5) of section 409.814, |
47 | Florida Statutes, are amended to read: |
48 | 409.814 Eligibility.--A child who has not reached 19 years |
49 | of age whose family income is equal to or below 200 percent of |
50 | the federal poverty level is eligible for the Florida KidCare |
51 | program as provided in this section. For enrollment in the |
52 | Children's Medical Services Network, a complete application |
53 | includes the medical or behavioral health screening. If, |
54 | subsequently, an individual is determined to be ineligible for |
55 | coverage, he or she must immediately be disenrolled from the |
56 | respective Florida KidCare program component. |
57 | (2) A child who is not eligible for Medicaid, but who is |
58 | eligible for the Florida KidCare program, may obtain health |
59 | benefits coverage under any of the other components listed in s. |
60 | 409.813 if such coverage is approved and available in the county |
61 | in which the child resides. However, a child who is eligible for |
62 | Medikids, including those eligible under subsection (5), may |
63 | participate in the Florida Healthy Kids program only if the |
64 | child has a sibling participating in the Florida Healthy Kids |
65 | program and the child's county of residence permits such |
66 | enrollment. |
67 | (5) A child whose family income is above 200 percent of |
68 | the federal poverty level or a child who is excluded under the |
69 | provisions of subsection (4) may apply for coverage and shall be |
70 | allowed to participate in the Florida KidCare program, excluding |
71 | the Medicaid program, but is subject to the following |
72 | provisions: |
73 | (a) The family is not eligible for premium assistance |
74 | payments and must pay the full cost of the premium, including |
75 | any administrative costs. |
76 | (b) The agency is authorized to place limits on enrollment |
77 | in Medikids by these children in order to avoid adverse |
78 | selection. The number of children participating in Medikids |
79 | whose family income exceeds 200 percent of the federal poverty |
80 | level must not exceed 10 percent of total enrollees in the |
81 | Medikids program. |
82 | (c) The board of directors of the Florida Healthy Kids |
83 | Corporation is authorized to place limits on enrollment of these |
84 | children in order to avoid adverse selection. In addition, the |
85 | board is authorized to offer a reduced benefit package to these |
86 | children in order to limit program costs for such families. The |
87 | number of children participating in the Florida Healthy Kids |
88 | program whose family income exceeds 200 percent of the federal |
89 | poverty level must not exceed 10 percent of total enrollees in |
90 | the Florida Healthy Kids program. |
91 | (d) Children described in this subsection are not counted |
92 | in the annual enrollment ceiling for the Florida KidCare |
93 | program. |
94 | Section 3. Subsection (5) of section 409.903, Florida |
95 | Statutes, is amended to read: |
96 | 409.903 Mandatory payments for eligible persons.--The |
97 | agency shall make payments for medical assistance and related |
98 | services on behalf of the following persons who the department, |
99 | or the Social Security Administration by contract with the |
100 | Department of Children and Family Services, determines to be |
101 | eligible, subject to the income, assets, and categorical |
102 | eligibility tests set forth in federal and state law. Payment on |
103 | behalf of these Medicaid eligible persons is subject to the |
104 | availability of moneys and any limitations established by the |
105 | General Appropriations Act or chapter 216. |
106 | (5) A pregnant woman for the duration of her pregnancy and |
107 | for the postpartum period as defined in federal law and rule, or |
108 | a child under age 1, if either is living in a family that has an |
109 | income which is at or below 150 percent of the most current |
110 | federal poverty level, or, effective January 1, 1992, that has |
111 | an income which is at or below 185 percent of the most current |
112 | federal poverty level. Such a person is not subject to an assets |
113 | test. Further, a pregnant woman who applies for eligibility for |
114 | the Medicaid program through a qualified Medicaid provider must |
115 | be offered the opportunity, subject to federal rules, to be made |
116 | presumptively eligible for the Medicaid program. Effective July |
117 | 1, 2005, eligibility for Medicaid services is eliminated for |
118 | women who have incomes above 150 percent of the most current |
119 | federal poverty level. |
120 | Section 4. Subsections (1) and (2) of section 409.904, |
121 | Florida Statutes, are amended to read: |
122 | 409.904 Optional payments for eligible persons.--The |
123 | agency may make payments for medical assistance and related |
124 | services on behalf of the following persons who are determined |
125 | to be eligible subject to the income, assets, and categorical |
126 | eligibility tests set forth in federal and state law. Payment on |
127 | behalf of these Medicaid eligible persons is subject to the |
128 | availability of moneys and any limitations established by the |
129 | General Appropriations Act or chapter 216. |
130 | (1)(a) From July 1, 2005, through December 31, 2005, |
131 | inclusive, a person who is age 65 or older or is determined to |
132 | be disabled, whose income is at or below 88 percent of federal |
133 | poverty level, and whose assets do not exceed established |
134 | limitations. |
135 | (b) Effective January 1, 2006, and subject to federal |
136 | waiver approval, a person who is age 65 or older or is |
137 | determined to be disabled, whose income is at or below 88 |
138 | percent of the federal poverty level, whose assets do not exceed |
139 | established limitations, and who is not eligible for Medicare, |
140 | or, if eligible for Medicare, is also eligible for and receiving |
141 | Medicaid-covered institutional care or hospice or home-based and |
142 | community-based services. The agency shall seek federal |
143 | authorization through a waiver to provide this coverage. |
144 | (2) A family, a pregnant woman, a child under age 21, a |
145 | person age 65 or over, or a blind or disabled person, who would |
146 | be eligible under any group listed in s. 409.903(1), (2), or |
147 | (3), except that the income or assets of such family or person |
148 | exceed established limitations. For a family or person in one of |
149 | these coverage groups, medical expenses are deductible from |
150 | income in accordance with federal requirements in order to make |
151 | a determination of eligibility. A family or person eligible |
152 | under the coverage known as the "medically needy," is eligible |
153 | to receive the same services as other Medicaid recipients, with |
154 | the exception of services in skilled nursing facilities and |
155 | intermediate care facilities for the developmentally disabled. |
156 | Effective July 1, 2005, the medically needy are eligible for |
157 | prescribed drug services only. |
158 | Section 5. Paragraph (b) of subsection (1) of section |
159 | 409.906, Florida Statutes, is amended to read: |
160 | 409.906 Optional Medicaid services.--Subject to specific |
161 | appropriations, the agency may make payments for services which |
162 | are optional to the state under Title XIX of the Social Security |
163 | Act and are furnished by Medicaid providers to recipients who |
164 | are determined to be eligible on the dates on which the services |
165 | were provided. Any optional service that is provided shall be |
166 | provided only when medically necessary and in accordance with |
167 | state and federal law. Optional services rendered by providers |
168 | in mobile units to Medicaid recipients may be restricted or |
169 | prohibited by the agency. Nothing in this section shall be |
170 | construed to prevent or limit the agency from adjusting fees, |
171 | reimbursement rates, lengths of stay, number of visits, or |
172 | number of services, or making any other adjustments necessary to |
173 | comply with the availability of moneys and any limitations or |
174 | directions provided for in the General Appropriations Act or |
175 | chapter 216. If necessary to safeguard the state's systems of |
176 | providing services to elderly and disabled persons and subject |
177 | to the notice and review provisions of s. 216.177, the Governor |
178 | may direct the Agency for Health Care Administration to amend |
179 | the Medicaid state plan to delete the optional Medicaid service |
180 | known as "Intermediate Care Facilities for the Developmentally |
181 | Disabled." Optional services may include: |
182 | (1) ADULT DENTAL SERVICES.-- |
183 | (b) Beginning January 1, 2005, The agency may pay for |
184 | dentures, the procedures required to seat dentures, and the |
185 | repair and reline of dentures, provided by or under the |
186 | direction of a licensed dentist, for a recipient who is 21 years |
187 | of age or older. This paragraph is repealed effective July 1, |
188 | 2005. |
189 | Section 6. Effective January 1, 2006, section 409.9065, |
190 | Florida Statutes, is repealed. |
191 | Section 7. Paragraph (b) of subsection (2) and subsection |
192 | (14) of section 409.908, Florida Statutes, are amended to read: |
193 | 409.908 Reimbursement of Medicaid providers.--Subject to |
194 | specific appropriations, the agency shall reimburse Medicaid |
195 | providers, in accordance with state and federal law, according |
196 | to methodologies set forth in the rules of the agency and in |
197 | policy manuals and handbooks incorporated by reference therein. |
198 | These methodologies may include fee schedules, reimbursement |
199 | methods based on cost reporting, negotiated fees, competitive |
200 | bidding pursuant to s. 287.057, and other mechanisms the agency |
201 | considers efficient and effective for purchasing services or |
202 | goods on behalf of recipients. If a provider is reimbursed based |
203 | on cost reporting and submits a cost report late and that cost |
204 | report would have been used to set a lower reimbursement rate |
205 | for a rate semester, then the provider's rate for that semester |
206 | shall be retroactively calculated using the new cost report, and |
207 | full payment at the recalculated rate shall be effected |
208 | retroactively. Medicare-granted extensions for filing cost |
209 | reports, if applicable, shall also apply to Medicaid cost |
210 | reports. Payment for Medicaid compensable services made on |
211 | behalf of Medicaid eligible persons is subject to the |
212 | availability of moneys and any limitations or directions |
213 | provided for in the General Appropriations Act or chapter 216. |
214 | Further, nothing in this section shall be construed to prevent |
215 | or limit the agency from adjusting fees, reimbursement rates, |
216 | lengths of stay, number of visits, or number of services, or |
217 | making any other adjustments necessary to comply with the |
218 | availability of moneys and any limitations or directions |
219 | provided for in the General Appropriations Act, provided the |
220 | adjustment is consistent with legislative intent. |
221 | (2) |
222 | (b) Subject to any limitations or directions provided for |
223 | in the General Appropriations Act, the agency shall establish |
224 | and implement a Florida Title XIX Long-Term Care Reimbursement |
225 | Plan (Medicaid) for nursing home care in order to provide care |
226 | and services in conformance with the applicable state and |
227 | federal laws, rules, regulations, and quality and safety |
228 | standards and to ensure that individuals eligible for medical |
229 | assistance have reasonable geographic access to such care. |
230 | 1. Changes of ownership or of licensed operator do not |
231 | qualify for increases in reimbursement rates associated with the |
232 | change of ownership or of licensed operator. The agency shall |
233 | amend the Title XIX Long Term Care Reimbursement Plan to provide |
234 | that the initial nursing home reimbursement rates, for the |
235 | operating, patient care, and MAR components, associated with |
236 | related and unrelated party changes of ownership or licensed |
237 | operator filed on or after September 1, 2001, are equivalent to |
238 | the previous owner's reimbursement rate. |
239 | 2. The agency shall amend the long-term care reimbursement |
240 | plan and cost reporting system to create direct care and |
241 | indirect care subcomponents of the patient care component of the |
242 | per diem rate. These two subcomponents together shall equal the |
243 | patient care component of the per diem rate. Separate cost-based |
244 | ceilings shall be calculated for each patient care subcomponent. |
245 | The direct care and indirect care subcomponents subcomponent of |
246 | the per diem rate shall be limited by the cost-based class |
247 | ceiling, and the indirect care subcomponent shall be limited by |
248 | the lower of a the cost-based class ceiling, a by the target |
249 | rate class ceiling, or an by the individual provider target for |
250 | each subcomponent. The agency shall adjust the patient care |
251 | component effective January 1, 2002. The cost to adjust the |
252 | direct care subcomponent shall be the net of the total funds |
253 | previously allocated for the case mix add-on. The agency shall |
254 | make the required changes to the nursing home cost reporting |
255 | forms to implement this requirement effective January 1, 2002. |
256 | 3. The direct care subcomponent shall include salaries and |
257 | benefits of direct care staff providing nursing services |
258 | including registered nurses, licensed practical nurses, and |
259 | certified nursing assistants who deliver care directly to |
260 | residents in the nursing home facility. This excludes nursing |
261 | administration, MDS, and care plan coordinators, staff |
262 | development, and staffing coordinator. |
263 | 4. All other patient care costs shall be included in the |
264 | indirect care cost subcomponent of the patient care per diem |
265 | rate. There shall be no costs directly or indirectly allocated |
266 | to the direct care subcomponent from a home office or management |
267 | company. |
268 | 5. On July 1 of each year, the agency shall report to the |
269 | Legislature direct and indirect care costs, including average |
270 | direct and indirect care costs per resident per facility and |
271 | direct care and indirect care salaries and benefits per category |
272 | of staff member per facility. |
273 | 6. In order to offset the cost of general and professional |
274 | liability insurance, the agency shall amend the plan to allow |
275 | for interim rate adjustments to reflect increases in the cost of |
276 | general or professional liability insurance for nursing homes. |
277 | This provision shall be implemented to the extent existing |
278 | appropriations are available. |
279 |
|
280 | It is the intent of the Legislature that the reimbursement plan |
281 | achieve the goal of providing access to health care for nursing |
282 | home residents who require large amounts of care while |
283 | encouraging diversion services as an alternative to nursing home |
284 | care for residents who can be served within the community. The |
285 | agency shall base the establishment of any maximum rate of |
286 | payment, whether overall or component, on the available moneys |
287 | as provided for in the General Appropriations Act. The agency |
288 | may base the maximum rate of payment on the results of |
289 | scientifically valid analysis and conclusions derived from |
290 | objective statistical data pertinent to the particular maximum |
291 | rate of payment. |
292 | (14) A provider of prescribed drugs shall be reimbursed |
293 | the least of the amount billed by the provider, the provider's |
294 | usual and customary charge, or the Medicaid maximum allowable |
295 | fee established by the agency, plus a dispensing fee. |
296 | (a) For pharmacies with less than $75,000 in average |
297 | aggregate monthly payments, the Medicaid maximum allowable fee |
298 | for ingredient cost will be based on the lower of: average |
299 | wholesale price (AWP) minus 15.4 percent, wholesaler acquisition |
300 | cost (WAC) plus 5.75 percent, the federal upper limit (FUL), the |
301 | state maximum allowable cost (SMAC), or the usual and customary |
302 | (UAC) charge billed by the provider. |
303 | (b) For pharmacies with $75,000 or more in average |
304 | aggregate monthly payments, the Medicaid maximum allowable fee |
305 | for ingredient cost will be based on the lower of: average |
306 | wholesale price (AWP) minus 17 percent, wholesaler acquisition |
307 | cost (WAC) plus 3.75 percent, the federal upper limit (FUL), the |
308 | state maximum allowable cost (SMAC), or the usual and customary |
309 | (UAC) charge billed by the provider. |
310 | (c) Medicaid providers are required to dispense generic |
311 | drugs if available at lower cost and the agency has not |
312 | determined that the branded product is more cost-effective, |
313 | unless the prescriber has requested and received approval to |
314 | require the branded product. The agency is directed to implement |
315 | a variable dispensing fee for payments for prescribed medicines |
316 | while ensuring continued access for Medicaid recipients. The |
317 | variable dispensing fee may be based upon, but not limited to, |
318 | either or both the volume of prescriptions dispensed by a |
319 | specific pharmacy provider, the volume of prescriptions |
320 | dispensed to an individual recipient, and dispensing of |
321 | preferred-drug-list products. The agency may increase the |
322 | pharmacy dispensing fee authorized by statute and in the annual |
323 | General Appropriations Act by $0.50 for the dispensing of a |
324 | Medicaid preferred-drug-list product and reduce the pharmacy |
325 | dispensing fee by $0.50 for the dispensing of a Medicaid product |
326 | that is not included on the preferred drug list. The agency may |
327 | establish a supplemental pharmaceutical dispensing fee to be |
328 | paid to providers returning unused unit-dose packaged |
329 | medications to stock and crediting the Medicaid program for the |
330 | ingredient cost of those medications if the ingredient costs to |
331 | be credited exceed the value of the supplemental dispensing fee. |
332 | The agency is authorized to limit reimbursement for prescribed |
333 | medicine in order to comply with any limitations or directions |
334 | provided for in the General Appropriations Act, which may |
335 | include implementing a prospective or concurrent utilization |
336 | review program. |
337 | Section 8. Paragraph (a) of subsection (39) of section |
338 | 409.912, Florida Statutes, is amended, and subsections (50) and |
339 | (51) are added to said section, to read: |
340 | 409.912 Cost-effective purchasing of health care.--The |
341 | agency shall purchase goods and services for Medicaid recipients |
342 | in the most cost-effective manner consistent with the delivery |
343 | of quality medical care. To ensure that medical services are |
344 | effectively utilized, the agency may, in any case, require a |
345 | confirmation or second physician's opinion of the correct |
346 | diagnosis for purposes of authorizing future services under the |
347 | Medicaid program. This section does not restrict access to |
348 | emergency services or poststabilization care services as defined |
349 | in 42 C.F.R. part 438.114. Such confirmation or second opinion |
350 | shall be rendered in a manner approved by the agency. The agency |
351 | shall maximize the use of prepaid per capita and prepaid |
352 | aggregate fixed-sum basis services when appropriate and other |
353 | alternative service delivery and reimbursement methodologies, |
354 | including competitive bidding pursuant to s. 287.057, designed |
355 | to facilitate the cost-effective purchase of a case-managed |
356 | continuum of care. The agency shall also require providers to |
357 | minimize the exposure of recipients to the need for acute |
358 | inpatient, custodial, and other institutional care and the |
359 | inappropriate or unnecessary use of high-cost services. The |
360 | agency may mandate prior authorization, drug therapy management, |
361 | or disease management participation for certain populations of |
362 | Medicaid beneficiaries, certain drug classes, or particular |
363 | drugs to prevent fraud, abuse, overuse, and possible dangerous |
364 | drug interactions. The Pharmaceutical and Therapeutics Committee |
365 | shall make recommendations to the agency on drugs for which |
366 | prior authorization is required. The agency shall inform the |
367 | Pharmaceutical and Therapeutics Committee of its decisions |
368 | regarding drugs subject to prior authorization. The agency is |
369 | authorized to limit the entities it contracts with or enrolls as |
370 | Medicaid providers by developing a provider network through |
371 | provider credentialing. The agency may limit its network based |
372 | on the assessment of beneficiary access to care, provider |
373 | availability, provider quality standards, time and distance |
374 | standards for access to care, the cultural competence of the |
375 | provider network, demographic characteristics of Medicaid |
376 | beneficiaries, practice and provider-to-beneficiary standards, |
377 | appointment wait times, beneficiary use of services, provider |
378 | turnover, provider profiling, provider licensure history, |
379 | previous program integrity investigations and findings, peer |
380 | review, provider Medicaid policy and billing compliance records, |
381 | clinical and medical record audits, and other factors. Providers |
382 | shall not be entitled to enrollment in the Medicaid provider |
383 | network. The agency is authorized to seek federal waivers |
384 | necessary to implement this policy. |
385 | (39)(a) The agency shall implement a Medicaid prescribed- |
386 | drug spending-control program that includes the following |
387 | components: |
388 | 1. Medicaid prescribed-drug coverage for brand-name drugs |
389 | for adult Medicaid recipients is limited to the dispensing of |
390 | three four brand-name drugs and three generic drugs per month |
391 | per recipient. Children are exempt from this restriction. |
392 | Antiretroviral agents are excluded from this limitation. No |
393 | requirements for prior authorization or other restrictions on |
394 | medications used to treat mental illnesses such as |
395 | schizophrenia, severe depression, or bipolar disorder may be |
396 | imposed on Medicaid recipients. Medications that will be |
397 | available without restriction for persons with mental illnesses |
398 | include atypical antipsychotic medications, conventional |
399 | antipsychotic medications, selective serotonin reuptake |
400 | inhibitors, and other medications used for the treatment of |
401 | serious mental illnesses. The agency shall also limit the amount |
402 | of a prescribed drug dispensed to no more than a 34-day supply. |
403 | The agency shall continue to provide unlimited generic drugs, |
404 | contraceptive drugs and items, and diabetic supplies. Although a |
405 | drug may be included on the preferred drug formulary, it would |
406 | not be exempt from the three-brand four-brand limit or the |
407 | generic drug limit. The agency may authorize exceptions to the |
408 | brand-name-drug restriction based upon the treatment needs of |
409 | the patients, only when such exceptions are based on prior |
410 | consultation provided by the agency or an agency contractor, but |
411 | the agency must establish procedures to ensure that: |
412 | a. There will be a response to a request for prior |
413 | consultation by telephone or other telecommunication device |
414 | within 24 hours after receipt of a request for prior |
415 | consultation; |
416 | b. A 72-hour supply of the drug prescribed will be |
417 | provided in an emergency or when the agency does not provide a |
418 | response within 24 hours as required by sub-subparagraph a.; and |
419 | c. Except for the exception for nursing home residents and |
420 | other institutionalized adults and except for drugs on the |
421 | restricted formulary for which prior authorization may be sought |
422 | by an institutional or community pharmacy, prior authorization |
423 | for an exception to the brand-name-drug restriction is sought by |
424 | the prescriber and not by the pharmacy. When prior authorization |
425 | is granted for a patient in an institutional setting beyond the |
426 | brand-name-drug restriction, such approval is authorized for 12 |
427 | months and monthly prior authorization is not required for that |
428 | patient. |
429 | 2. Reimbursement to pharmacies for Medicaid prescribed |
430 | drugs shall be set at the lesser of: |
431 | a. The average wholesale price (AWP) minus 15.4 percent, |
432 | the wholesaler acquisition cost (WAC) plus 5.75 percent, the |
433 | federal upper limit (FUL), the state maximum allowable cost |
434 | (SMAC), or the usual and customary (UAC) charge billed by the |
435 | provider for pharmacies with less than $75,000 in average |
436 | aggregate monthly payments. |
437 | b. The average wholesale price (AWP) minus 17 percent, |
438 | wholesaler acquisition cost (WAC) plus 3.75 percent, the federal |
439 | upper limit (FUL), the state maximum allowable cost (SMAC), or |
440 | the usual and customary (UAC) charge billed by the provider for |
441 | pharmacies with $75,000 or more in average aggregate monthly |
442 | payments. |
443 | 3. The agency shall develop and implement a process for |
444 | managing the drug therapies of Medicaid recipients who are using |
445 | significant numbers of prescribed drugs each month. The |
446 | management process may include, but is not limited to, |
447 | comprehensive, physician-directed medical-record reviews, claims |
448 | analyses, and case evaluations to determine the medical |
449 | necessity and appropriateness of a patient's treatment plan and |
450 | drug therapies. The agency may contract with a private |
451 | organization to provide drug-program-management services. The |
452 | Medicaid drug benefit management program shall include |
453 | initiatives to manage drug therapies for HIV/AIDS patients, |
454 | patients using 20 or more unique prescriptions in a 180-day |
455 | period, and the top 1,000 patients in annual spending. The |
456 | agency shall enroll any Medicaid recipient in the drug benefit |
457 | management program if he or she meets the specifications of this |
458 | provision and is not enrolled in a Medicaid health maintenance |
459 | organization. |
460 | 4. The agency may limit the size of its pharmacy network |
461 | based on need, competitive bidding, price negotiations, |
462 | credentialing, or similar criteria. The agency shall give |
463 | special consideration to rural areas in determining the size and |
464 | location of pharmacies included in the Medicaid pharmacy |
465 | network. A pharmacy credentialing process may include criteria |
466 | such as a pharmacy's full-service status, location, size, |
467 | patient educational programs, patient consultation, disease- |
468 | management services, and other characteristics. The agency may |
469 | impose a moratorium on Medicaid pharmacy enrollment when it is |
470 | determined that it has a sufficient number of Medicaid- |
471 | participating providers. |
472 | 5. The agency shall develop and implement a program that |
473 | requires Medicaid practitioners who prescribe drugs to use a |
474 | counterfeit-proof prescription pad for Medicaid prescriptions. |
475 | The agency shall require the use of standardized counterfeit- |
476 | proof prescription pads by Medicaid-participating prescribers or |
477 | prescribers who write prescriptions for Medicaid recipients. The |
478 | agency may implement the program in targeted geographic areas or |
479 | statewide. |
480 | 6. The agency may enter into arrangements that require |
481 | manufacturers of generic drugs prescribed to Medicaid recipients |
482 | to provide rebates of at least 15.1 percent of the average |
483 | manufacturer price for the manufacturer's generic products. |
484 | These arrangements shall require that if a generic-drug |
485 | manufacturer pays federal rebates for Medicaid-reimbursed drugs |
486 | at a level below 15.1 percent, the manufacturer must provide a |
487 | supplemental rebate to the state in an amount necessary to |
488 | achieve a 15.1-percent rebate level. |
489 | 7. The agency may establish a preferred drug formulary in |
490 | accordance with 42 U.S.C. s. 1396r-8, and, pursuant to the |
491 | establishment of such formulary, it is authorized to negotiate |
492 | supplemental rebates from manufacturers that are in addition to |
493 | those required by Title XIX of the Social Security Act and at no |
494 | less than 14 percent of the average manufacturer price as |
495 | defined in 42 U.S.C. s. 1936 on the last day of a quarter unless |
496 | the federal or supplemental rebate, or both, equals or exceeds |
497 | 29 percent. There is no upper limit on the supplemental rebates |
498 | the agency may negotiate. The agency may determine that specific |
499 | products, brand-name or generic, are competitive at lower rebate |
500 | percentages. Agreement to pay the minimum supplemental rebate |
501 | percentage will guarantee a manufacturer that the Medicaid |
502 | Pharmaceutical and Therapeutics Committee will consider a |
503 | product for inclusion on the preferred drug formulary. However, |
504 | a pharmaceutical manufacturer is not guaranteed placement on the |
505 | formulary by simply paying the minimum supplemental rebate. |
506 | Agency decisions will be made on the clinical efficacy of a drug |
507 | and recommendations of the Medicaid Pharmaceutical and |
508 | Therapeutics Committee, as well as the price of competing |
509 | products minus federal and state rebates. The agency is |
510 | authorized to contract with an outside agency or contractor to |
511 | conduct negotiations for supplemental rebates. For the purposes |
512 | of this section, the term "supplemental rebates" means cash |
513 | rebates. Effective July 1, 2004, value-added programs as a |
514 | substitution for supplemental rebates are prohibited. The agency |
515 | is authorized to seek any federal waivers to implement this |
516 | initiative. |
517 | 8. The agency shall establish an advisory committee for |
518 | the purposes of studying the feasibility of using a restricted |
519 | drug formulary for nursing home residents and other |
520 | institutionalized adults. The committee shall be comprised of |
521 | seven members appointed by the Secretary of Health Care |
522 | Administration. The committee members shall include two |
523 | physicians licensed under chapter 458 or chapter 459; three |
524 | pharmacists licensed under chapter 465 and appointed from a list |
525 | of recommendations provided by the Florida Long-Term Care |
526 | Pharmacy Alliance; and two pharmacists licensed under chapter |
527 | 465. |
528 | 9. The Agency for Health Care Administration shall expand |
529 | home delivery of pharmacy products. To assist Medicaid patients |
530 | in securing their prescriptions and reduce program costs, the |
531 | agency shall expand its current mail-order-pharmacy diabetes- |
532 | supply program to include all generic and brand-name drugs used |
533 | by Medicaid patients with diabetes. Medicaid recipients in the |
534 | current program may obtain nondiabetes drugs on a voluntary |
535 | basis. This initiative is limited to the geographic area covered |
536 | by the current contract. The agency may seek and implement any |
537 | federal waivers necessary to implement this subparagraph. |
538 | 10. The agency shall limit to one dose per month any drug |
539 | prescribed to treat erectile dysfunction. |
540 | 11.a. The agency shall implement a Medicaid behavioral |
541 | drug management system. The agency may contract with a vendor |
542 | that has experience in operating behavioral drug management |
543 | systems to implement this program. The agency is authorized to |
544 | seek federal waivers to implement this program. |
545 | b. The agency, in conjunction with the Department of |
546 | Children and Family Services, may implement the Medicaid |
547 | behavioral drug management system that is designed to improve |
548 | the quality of care and behavioral health prescribing practices |
549 | based on best practice guidelines, improve patient adherence to |
550 | medication plans, reduce clinical risk, and lower prescribed |
551 | drug costs and the rate of inappropriate spending on Medicaid |
552 | behavioral drugs. The program shall include the following |
553 | elements: |
554 | (I) Provide for the development and adoption of best |
555 | practice guidelines for behavioral health-related drugs such as |
556 | antipsychotics, antidepressants, and medications for treating |
557 | bipolar disorders and other behavioral conditions; translate |
558 | them into practice; review behavioral health prescribers and |
559 | compare their prescribing patterns to a number of indicators |
560 | that are based on national standards; and determine deviations |
561 | from best practice guidelines. |
562 | (II) Implement processes for providing feedback to and |
563 | educating prescribers using best practice educational materials |
564 | and peer-to-peer consultation. |
565 | (III) Assess Medicaid beneficiaries who are outliers in |
566 | their use of behavioral health drugs with regard to the numbers |
567 | and types of drugs taken, drug dosages, combination drug |
568 | therapies, and other indicators of improper use of behavioral |
569 | health drugs. |
570 | (IV) Alert prescribers to patients who fail to refill |
571 | prescriptions in a timely fashion, are prescribed multiple same- |
572 | class behavioral health drugs, and may have other potential |
573 | medication problems. |
574 | (V) Track spending trends for behavioral health drugs and |
575 | deviation from best practice guidelines. |
576 | (VI) Use educational and technological approaches to |
577 | promote best practices, educate consumers, and train prescribers |
578 | in the use of practice guidelines. |
579 | (VII) Disseminate electronic and published materials. |
580 | (VIII) Hold statewide and regional conferences. |
581 | (IX) Implement a disease management program with a model |
582 | quality-based medication component for severely mentally ill |
583 | individuals and emotionally disturbed children who are high |
584 | users of care. |
585 | c. If the agency is unable to negotiate a contract with |
586 | one or more manufacturers to finance and guarantee savings |
587 | associated with a behavioral drug management program by |
588 | September 1, 2004, the four-brand drug limit and preferred drug |
589 | list prior-authorization requirements shall apply to mental |
590 | health-related drugs, notwithstanding any provision in |
591 | subparagraph 1. The agency is authorized to seek federal waivers |
592 | to implement this policy. |
593 | 12. The agency is authorized to contract for drug rebate |
594 | administration, including, but not limited to, calculating |
595 | rebate amounts, invoicing manufacturers, negotiating disputes |
596 | with manufacturers, and maintaining a database of rebate |
597 | collections. |
598 | 13. The agency may specify the preferred daily dosing form |
599 | or strength for the purpose of promoting best practices with |
600 | regard to the prescribing of certain drugs as specified in the |
601 | General Appropriations Act and ensuring cost-effective |
602 | prescribing practices. |
603 | 14. The agency may require prior authorization for the |
604 | off-label use of Medicaid-covered prescribed drugs as specified |
605 | in the General Appropriations Act. The agency may, but is not |
606 | required to, preauthorize the use of a product for an indication |
607 | not in the approved labeling. Prior authorization may require |
608 | the prescribing professional to provide information about the |
609 | rationale and supporting medical evidence for the off-label use |
610 | of a drug. |
611 | 15. The agency shall implement a return and reuse program |
612 | for drugs dispensed by pharmacies to institutional recipients, |
613 | which includes payment of a $5 restocking fee for the |
614 | implementation and operation of the program. The return and |
615 | reuse program shall be implemented electronically and in a |
616 | manner that promotes efficiency. The program must permit a |
617 | pharmacy to exclude drugs from the program if it is not |
618 | practical or cost-effective for the drug to be included and must |
619 | provide for the return to inventory of drugs that cannot be |
620 | credited or returned in a cost-effective manner. |
621 | (50) The agency may implement a program of all-inclusive |
622 | care for children to reduce the need for hospitalization of |
623 | children, as appropriate. The purpose of the program is to |
624 | provide in-home hospice-like support services to children |
625 | diagnosed with a life-threatening illness who are enrolled in |
626 | the Children's Medical Services Network. The agency, in |
627 | consultation with the Department of Health, may implement the |
628 | program of all-inclusive care for children after obtaining |
629 | approval from the Centers for Medicare and Medicaid Services. |
630 | (51) By July 1, 2005, the agency shall develop a plan for |
631 | implementing the delivery of comprehensive vision care services |
632 | to Medicaid recipients through a capitated prepaid arrangement. |
633 | The plan shall include contracting with a private entity or |
634 | entities to provide for the comprehensive vision care services |
635 | through a capitated prepaid arrangement. However, the entity |
636 | must: |
637 | (a) Be licensed under chapter 627. |
638 | (b) Have sufficient financial resources. |
639 | (c) Have a contracted provider network that has statewide |
640 | coverage. |
641 | (d) Have experience in providing medical and surgical |
642 | vision care services. |
643 | (e) Have experience with the implementation of large |
644 | statewide contracts. As used in this section, the term "vision |
645 | care services" means covered vision services, including routine, |
646 | medical, and surgical vision care services that are available to |
647 | Medicaid recipients. If necessary, the agency shall seek federal |
648 | approval to contract with a single entity meeting these |
649 | requirements to provide vision care services to all Medicaid |
650 | recipients. The entity must offer sufficient choice of providers |
651 | within its network to ensure access to care for the recipient |
652 | and the opportunity to select a provider with whom the recipient |
653 | is satisfied. |
654 | Section 9. Paragraph (k) of subsection (2) of section |
655 | 409.9122, Florida Statutes, is amended to read: |
656 | 409.9122 Mandatory Medicaid managed care enrollment; |
657 | programs and procedures.-- |
658 | (2) |
659 | (k) When a Medicaid recipient does not choose a managed |
660 | care plan or MediPass provider, the agency shall assign the |
661 | Medicaid recipient to a managed care plan, except in those |
662 | counties in which there are fewer than two managed care plans |
663 | accepting Medicaid enrollees, in which case assignment shall be |
664 | to a managed care plan or a MediPass provider. Medicaid |
665 | recipients in counties with fewer than two managed care plans |
666 | accepting Medicaid enrollees who are subject to mandatory |
667 | assignment but who fail to make a choice shall be assigned to |
668 | managed care plans until an enrollment of 40 percent in MediPass |
669 | and 60 percent in managed care plans is achieved. Once that |
670 | enrollment is achieved, the assignments shall be divided in |
671 | order to maintain an enrollment in MediPass and managed care |
672 | plans which is in a 40 percent and 60 percent proportion, |
673 | respectively. In geographic areas where the agency is |
674 | contracting for the provision of comprehensive behavioral health |
675 | services through a capitated prepaid arrangement, recipients who |
676 | fail to make a choice shall be assigned equally to MediPass or a |
677 | managed care plan. For purposes of this paragraph, when |
678 | referring to assignment, the term "managed care plans" includes |
679 | exclusive provider organizations, provider service networks, |
680 | Children's Medical Services Network, minority physician |
681 | networks, and pediatric emergency department diversion programs |
682 | authorized by this chapter or the General Appropriations Act. |
683 | When making assignments, the agency shall take into account the |
684 | following criteria: |
685 | 1. A managed care plan has sufficient network capacity to |
686 | meet the need of members. |
687 | 2. The managed care plan or MediPass has previously |
688 | enrolled the recipient as a member, or one of the managed care |
689 | plan's primary care providers or MediPass providers has |
690 | previously provided health care to the recipient. |
691 | 3. The agency has knowledge that the member has previously |
692 | expressed a preference for a particular managed care plan or |
693 | MediPass provider as indicated by Medicaid fee-for-service |
694 | claims data, but has failed to make a choice. |
695 | 4. The managed care plan's or MediPass primary care |
696 | providers are geographically accessible to the recipient's |
697 | residence. |
698 | 5. The agency has authority to make mandatory assignments |
699 | based on quality of service and performance of managed care |
700 | plans. |
701 | Section 10. Subsections (6) and (7) are added to section |
702 | 409.9124, Florida Statutes, to read: |
703 | 409.9124 Managed care reimbursement.-- |
704 | (6) The agency shall develop rates for children age 0-3 |
705 | months and separate rates for children age 4-12 months. The |
706 | agency shall amend the payment methodology for participating |
707 | Medicaid-managed health care plans to comply with this |
708 | subsection. |
709 | (7) The agency shall not pay rates at per-member per-month |
710 | averages higher than that allowed for in the General |
711 | Appropriations Act. |
712 | Section 11. Except as otherwise provided herein, this act |
713 | shall take effect July 1, 2005. |
714 |
|
715 |
|
716 | ================= T I T L E A M E N D M E N T ================= |
717 | Remove the entire title and insert: |
718 | A bill to be entitled |
719 | An act relating to health care; amending s. 400.23, F.S.; |
720 | delaying a nursing home staffing increase; amending s. |
721 | 409.814, F.S.; granting more children access to the |
722 | Florida KidCare program; amending s. 409.903, F.S.; |
723 | deleting a provision eliminating eligibility for Medicaid |
724 | services for certain women; amending s. 409.904, F.S.; |
725 | providing for the Agency for Health Care Administration to |
726 | pay for medical assistance for certain Medicaid-eligible |
727 | persons; deleting a limitation on eligibility for coverage |
728 | under the medically needy program; amending s. 409.906, |
729 | F.S.; deleting a repeal of a provision that provides adult |
730 | denture services; repealing s. 409.9065, F.S., relating to |
731 | pharmaceutical expense assistance; amending s. 409.908, |
732 | F.S.; revising provisions relating to the long-term care |
733 | reimbursement and cost reporting system; revising |
734 | provisions relating to the Medicaid maximum allowable fee |
735 | for certain pharmacies; amending s. 409.912, F.S.; |
736 | revising components of the Medicaid prescribed-drug |
737 | spending-control program; authorizing the agency to |
738 | implement a program of all-inclusive care for certain |
739 | children; authorizing the agency to adopt rules; requiring |
740 | a plan for comprehensive vision care services; amending s. |
741 | 409.9122, F.S.; deleting assignment requirement for |
742 | recipients in areas with capitated behavioral health |
743 | services; amending s. 409.9124, F.S.; requiring the agency |
744 | to develop managed care rates for children of specified |
745 | ages and to amend the methodology for reimbursing managed |
746 | care plans to comply therewith; limiting the amount of |
747 | reimbursement; providing effective dates. |